Christopher M. Booth

Research interests

Publications

• ESMO Guidance for Reporting Oncology real-World evidence (GROW)

  Annals of Oncology · 2023 · https://doi.org/10.1016/j.annonc.2023.10.001

• Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey

  The Lancet Oncology · 2021 · https://doi.org/10.1016/s1470-2045(21)00463-0

• Evolution of the Randomized Clinical Trial in the Era of Precision Oncology

  JAMA Oncology · 2021 · https://doi.org/10.1001/jamaoncol.2021.0379

• An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries

  JAMA Oncology · 2021 · https://doi.org/10.1001/jamaoncol.2020.7478

• Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic

  Nature Reviews Clinical Oncology · 2020 · https://doi.org/10.1038/s41571-020-0362-6

• Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis

  BMJ · 2019 · https://doi.org/10.1136/bmj.l5221

• Real-world data: towards achieving the achievable in cancer care

  Nature Reviews Clinical Oncology · 2019 · https://doi.org/10.1038/s41571-019-0167-7

• Acute Kidney Injury in Patients Receiving Systemic Treatment for Cancer: A Population-Based Cohort Study

  JNCI Journal of the National Cancer Institute · 2018 · https://doi.org/10.1093/jnci/djy167

• Delivery of meaningful cancer care: a retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworks

  The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30415-1

• Relevance of randomised controlled trials in oncology

  The Lancet Oncology · 2016 · https://doi.org/10.1016/s1470-2045(16)30572-1

• Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement

  Journal of Clinical Oncology · 2016 · https://doi.org/10.1200/jco.2015.65.9797

• Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence

  British Journal of Cancer · 2014 · https://doi.org/10.1038/bjc.2013.725

• Progression-Free Survival: Meaningful or Simply Measurable?

  Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2011.38.7571

• Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer

  JAMA · 2011 · https://doi.org/10.1001/jama.2011.749

• The impact of socioeconomic status on stage of cancer at diagnosis and survival

  Cancer · 2010 · https://doi.org/10.1002/cncr.25427

• Evolution of the Randomized Controlled Trial in Oncology Over Three Decades

  Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2008.16.5456

• The Colon Health and Life-Long Exercise Change Trial: A Randomized Trial of the National Cancer Institute of Canada Clinical Trials Group

  Current Oncology · 2008 · https://doi.org/10.3747/co.v15i6.378

• Does This Patient With Headache Have a Migraine or Need Neuroimaging?

  JAMA · 2006 · https://doi.org/10.1001/jama.296.10.1274

• Is This Patient Dead, Vegetative, or Severely Neurologically Impaired?

  JAMA · 2004 · https://doi.org/10.1001/jama.291.7.870

• Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area

  JAMA · 2003 · https://doi.org/10.1001/jama.289.21.joc30885

Current projects

No projects listed.